Effect of misoprostol on the secretion of histamine from basophils of whole blood

Annals of Allergy, Asthma and Immunology

Volumn 84, Issue 3, 2000, Pages 361-365

  Babakhin, Alexander A ^a   Nolte, Hendrik ^c   Dubuske, Lawrence M ^b  

^a INSTITUTE OF IMMUNOLOGY   (Russian Federation)

^b Immunology Research Institute of New England   (United States)

^c Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; PROSTAGLANDIN E1 DERIVATIVE;

ALLERGY; ARTICLE; BASOPHIL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; HISTAMINE RELEASE; HUMAN; PRIORITY JOURNAL;

EID: 0034064458     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62787-1     Document Type: Article

References (18)

1. Collins PW, Dajani EZ, Driskill DR, et al. Synthesis and gastric anti-secretory properties of 15-deoxy-16-hydroxy-prostaglandin E analogues. J Med Chem 1977;20:1152.
2. Shield MJ. Novel applications of misoprostol. Pharmacol Ther 1995;65(1): 125-147.
3. Pearce FL, Flint KC, Leung KB. Some studies on human pulmonary mast cells obtained by bronchoalveolar lavage and by enzymatic dissociation of whole lung tissue. Natl Arch Allergy Appl Immunol 1987;82:507-512.
4. Marcisz C, Jonderko G, Gina R. Effect of misoprostol, a synthetic equivalent of prostaglandin E1 on bronchodilation in bronchial spasm. Pol Tyg Lek 1992;47:733-734.
5. Shield MJ. Misoprostol: new frontiers; benefits beyond the gastrointestinal. Scand J Rheumatol 1992;92(suppl): 31-52.
6. Nolte H. The role of mast cells and basophils in immunoregulation. Allergy Asthma Proc 1996;17:17-21.
7. Nolte H. The clinical utility of basophil histamine release. Allergy Proc 1993;14:251-254.
8. Nolte H, Storm K, Schiotz PO. Diagnostic value of a glass fiber based histamine analysis for allergy testing in children. Allergy 1990;45:213-223.
9. Ohtsu H, Fujimoto Y, Yamauchi K, et al. Pharmacological effect of KCO-404 on leukotriene release from human leukocytes induced by ionophore A23187. Int Arch Allergy Appl Immunol 1989;(2-3);306-310.
10. 2-antagonists famotidine and nizatidine and the cytoprotectant misoprostol on human colonic and rat peritoneal mast cells. Agents Actions 1994;41 Spec No:C51-51.
11. Hogoboam CM, Bissonnette EY, Chin BC, et al. Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology 1993; 104(1):122-129.
12. Smith WG, Thompson JM, Kowalski DL, McKearn LP. Inhaled misoprostol blocks guinea pig antigen-induced bronchoconstriction and airway inflammation. Am J Respir Crit Care Med 1996;154(Pt1):295-299.
13. Szmidt M, Wasiak W. The influence of misoprostol on post-aspirin bronchoconstriction in patients with aspirin-sensitive asthma. Pneumonol Allergol Pol 1995;63(9-10):544-552.
14. Marcisz C, Jonderko G, Gina R, Szkliniarz J. Effect of misoprostol, a synthetic equivalent of prostaglandin E1, on bronchodilation in bronchial spasm. Pol Tyg Lek 1992;47(34035): 733-734.
15. Reder AT, Thapar M, Sapugay AM, Jensen MA. Prostaglandins and inhibitors of arachidonate metabolism suppress experimental allergic encephalomyelitis. J Neuroimmunol 1994; 54(1-2):117-127.
16. Reiman HJ, Lewin J, Schmidt U, et al. Prostaglandins 1987;33(suppl): 105-116.
17. Sandvik AK, Waldum HL. Aspects of the regulation of gastric histamine release. Scand J Gastroenterol 1991; 180(suppl):108-112.
18. Pollak R, Dumble LJ, Wiederkehr JC, et al. The immunosuppressive properties of new oral prostaglandin E1 analogs. Transplantation 1990;50(5): 834-838.